MedPath

Prognosis study in patients underwent electroconvulsive therapy (ECT)

Not Applicable
Conditions
Severe or drug resistant major depressive disorder (MDD) with administration of initial electroconvulsive therapy (ECT)
Registration Number
JPRN-UMIN000030458
Lead Sponsor
Department of Psychiatry, Shiga University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Patients diagnosed as the other axis I and II disorders and neurologic illnesses, and having a history of ECT.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diagnostic change from MDD to bipolar disorder (BP) during the 3 years of followup period after receiving ECT
Secondary Outcome Measures
NameTimeMethod
Relapse occurred during the 3 years of follow up period after receiving ECT Period until relapse of depression after receiving ECT Usage of remission maintenance therapy after receiving ECT
© Copyright 2025. All Rights Reserved by MedPath